Everyone should have access to healthcare, even in remote regions. In the #nanoporeconf studio, Robert A. Edwards shared how portable nanopore sequencing has the potential to address gaps, making genomics more accessible to everyone.

Methylation is becoming a key biomarker in neurodegenerative disease. As Kim Billingsley put it, you need to see the variant and the epigenetics together on the same molecule, in the same run. With nanopore, you get that for free, without needing a separate assay. #Nanoporeconf